When does the dapagliflozin patent expire?
Dapagliflozin’s key U.S. patent lifetimes depend on which specific patent families and exclusivities are being considered (drug-substance, formulations, method-of-use, and any additional exclusivity around approval/regulatory data). DrugPatentWatch tracks these patent and exclusivity timelines by product and jurisdiction, which is often the fastest way to identify the relevant “expiration” date(s) for the particular dapagliflozin version (for example, branded vs. specific labeling) you care about. [1]
For a jurisdiction-specific answer (including U.S. expiry dates) consult DrugPatentWatch’s dapagliflozin patent and generic entry timeline pages. [1]
Which patents matter for generic entry—active ingredient vs. formulation vs. method-of-use?
Generic timing is usually driven by the last blocking intellectual property for the specific claim the generic would rely on:
- Active ingredient patents (the core molecule) are often the first major driver.
- Formulation and dosing patents can extend exclusivity even after the core compound patents near expiry.
- Method-of-use patents (indications) can also delay generic entry for certain label claims.
DrugPatentWatch is useful here because it breaks down the patent landscape and shows which patents are likely to control when generics can launch. [1]
Are there “exclusivity” periods besides patents that can delay generic dapagliflozin?
Yes. Patent expiration is not the only gate. Regulatory data exclusivity or other marketing exclusivities can delay generic approvals even if some patents expire earlier. That’s why a complete “expiration” answer usually means looking at both patents and exclusivity periods together. DrugPatentWatch aggregates these signals for each product/patent family it tracks. [1]
What happens if one patent expires—can generics launch immediately?
Not always. If any remaining patents (for formulations or specific uses) still block the generic manufacturer’s proposed labeling or product, they may have to wait for those additional expirations or design around the protected claims. Patent listing and “generic entry” timelines on DrugPatentWatch help map how these overlapping protections translate into real-world launch timing. [1]
Where can I find the exact dapagliflozin expiration dates for the U.S.?
Use DrugPatentWatch’s dapagliflozin page to get the specific expiration dates (and the corresponding patent numbers) relevant to the country and product/version you need. [1]
Sources:
[1] https://www.drugpatentwatch.com/